A Win For Q32 Bio Inc.
Mon, Jul 13, 2026 at 07:33 PM
Q32 Bio Inc. (QTTB:NASDAQ) soared at $21.38, a gain of 90.7%. On Mon, Jul 13, 2026, QTTB:NASDAQ touched a New 2-Week High of $21.38. The stock appeared on our News Catalysts scanner on Mon, Jul 13, 2026 at 06:29 PM in the 'PUBLIC OFFERING' category. From Mon, Jun 29, 2026, the stock recorded 44.44% Up Days and 50.00% Green Days
About Q32 Bio Inc. (QTTB:NASDAQ)
Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the...
Top 10 Gainers:
- Twin Vee Powercats Co. (VEEE:NASDAQ), 415.77%
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Q32 Bio Inc. (QTTB:NASDAQ), 90.72%
- Agenus Inc. (AGEN:NASDAQ), 82.69%
- Mint Incorporation Limited (MIMI:NASDAQ), 37.67%
- Brera Holdings PLC (SLMT:NASDAQ), 35.58%
- Eshallgo Inc. (EHGO:NASDAQ), 29.27%
- Sky Quarry Inc. (SKYQ:NASDAQ), 25.47%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 24.55%
- Actuate Therapeutics, Inc. Common stock (ACTU:NASDAQ), 23.97%